Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01SAY
|
|||
| Former ID |
DIB012141
|
|||
| Drug Name |
Sipuleucel-T
|
|||
| Synonyms |
APC8015
Click to Show/Hide
|
|||
| Indication | Prostate cancer [ICD-11: 2C82.0; ICD-9: 185] | Approved | [1] | |
| Human immunodeficiency virus-1 infection [ICD-11: 1C62; ICD-10: B20-B24] | Phase 3 | [2] | ||
| Company |
Dendreon
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services | |||
| REF 2 | ClinicalTrials.gov (NCT01133704) Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate Cancer. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.